Evaluating Hair Camouflage as a Tool for Black Women With Alopecia: A Critical Review
January 18th 2024Black women with alopecia often struggle between concealing their hair loss and protecting their fragile scalps, all while seeking to express their cultural identity and build self-confidence.
Read More
CMS has announced new federal rules that require health insurers to streamline requests to cover treatments; nearly 50,000 veterans used the emergency suicide prevention program launched by the Department of Veteran Affairs in 2023; the FDA recently authorized the first artificial intelligence (AI)-powered medical device to help doctors detect the most common forms of skin cancer.
Read More
New Study Series Addresses Racial Inequities in Pediatric Care, Need for Policy Reform
January 17th 2024The findings demonstrate the critical need for immediate policy reforms to tackle structural racism and promote equitable pediatric care in the US for children regardless of race or ethnicity.
Read More
What We’re Reading: Health Insurance Premiums; Drug Price Hikes; Postpartum Depression Pill Access
January 17th 2024Families with workplace health insurance may have missed out on $125,000 in earnings over the past 3 decades due to rising premiums; so far, there have been about 600 drug price hikes in January; experts worry that minority and low-income people will not have easy access to zuranolone, the first FDA-approved postpartum depression pill.
Read More
Ultrasound Cycloplasty, Endoscopic Cyclophotocoagulation Can Reduce IOP in Secondary Glaucoma
January 17th 2024Endoscopic cyclophotocoagulation had better effect at early stages and ultrasound cycloplasty had higher safety and tolerance when treating intraocular pressure (IOP) in patients with secondary glaucoma.
Read More
Online Workshop Reveals Patient, Future Research Priorities in MDS
January 17th 2024Myelodysplastic syndrome is an extremely heterogeneous disease, and there is no definitive cure, so these investigators wanted a better understanding of patients’ priorities regarding their care, quality of life, and communication with the care team.
Read More
POSSUM, Other Scoring Systems Unable to Estimate Perioperative Complications in CRC
January 16th 2024Mortality and morbidity in patients with colorectal cancer (CRC) cannot be accurately predicted using the Physiological and Operative Severity Score for the enumeration of Mortality and Morbidity (POSSUM) in the present day.
Read More
Real-Time CGM Shows Benefits Over Intermittently Scanned CGM in T1D
January 16th 2024In a systematic review and meta-analysis, real-time continuous glucose monitoring (CGM) demonstrated benefits in terms of time in range, hypoglycemia, and hyperglycemia among patients with type 1 diabetes (T1D).
Read More
Gabapentinoid Use in COPD Associated With Increased Severe Exacerbation Risk, Study Says
January 15th 2024Gabapentinoid use, namely gabapentin and pregabalin, was associated with increased risk for severe chronic obstructive pulmonary disease (COPD) exacerbation in patients with epilepsy, neuropathic pain, and other chronic pain.
Read More
Navigating the Biosimilar Frontier: Opportunities and Challenges in 2024
January 14th 2024Biosimilars offer substantial promise for a new era of accessibility and affordability for patients and the broader health care industry, but better understanding of these products from payers and providers is necessary for biosimilars to reach their full potential in the US.
Read More
High White Blood Cell Counts Are Associated With Long-Term Acute COPD Exacerbations, Study Says
January 13th 2024The study's findings suggest that high baseline white blood cell count, particularly high neutrophil count, was associated with a higher incidence of long-term acute exacerbation of chronic obstructive pulmonary disease (COPD).
Read More
Health Equity and Access Weekly Roundup: January 13, 2024
January 13th 2024The Center on Health Equity and Access provides up-to-date news, showcases research advancements, and ongoing initiatives dedicated to tackling healthcare disparities and enhancing overall accessibility to outstanding care.
Read More
Study Explores Treatment Discontinuation Rates, Resource Utilization Among Patients With CLL/SLL
January 12th 2024A real-world study found that patients treated with Bruton tyrosine kinase inhibitors had lower rates of treatment discontinuation and health care resource utilization compared with other first- and second-line treatment regimens.
Read More